Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Perinatal lethal osteogenesis imperfecta

W G Cole1, R Dalgleish

  • 1Department of Medical Genetics, University of Toronto, Ontario, Canada.

Journal of Medical Genetics
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency.

Climacteric : the journal of the International Menopause Society·2018
Same author

Acute osteomyelitis overview.

Orthopedics·2014
Same author

Lack of association between ESR1 gene polymorphisms and premature ovarian failure in Serbian women.

Climacteric : the journal of the International Menopause Society·2013
Same author

Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variation.

Genetics and molecular research : GMR·2011
Same author

Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).

European journal of human genetics : EJHG·2011
Same author

Accident prevention.

American journal of public health and the nation's health·2010
Same journal

Longest surviving patient with a homozygous splice-altering <i>EGFR</i> pathogenic variant presenting with skin autoinflammation and a Bartter-like salt-losing tubulopathy.

Journal of medical genetics·2026
Same journal

Functional characterisation and pathological significance of variants of <i>MEF2C</i> promoter in tetralogy of Fallot.

Journal of medical genetics·2026
Same journal

Identification of biallelic loss-of-function <i>PREP</i> variants in three individuals with syndromic intellectual disability.

Journal of medical genetics·2026
Same journal

Inherited retinal disease genes with dual inheritance patterns: insights from the IRD-PT registry.

Journal of medical genetics·2026
Same journal

Interpreting <i>TP53</i> variants: somatic mosaicism and <i>ERCC6L2</i>-driven clonal evolution.

Journal of medical genetics·2026
Same journal

Review of estimates of birth incidence and population prevalence over time and between countries of the rare neurodevelopmental condition Prader-Willi syndrome.

Journal of medical genetics·2026
See all related articles

Perinatal lethal osteogenesis imperfecta, caused by mutations in COL1A1/COL1A2 genes, disrupts type I collagen structure. This leads to impaired bone formation and severe skeletal fragility in newborns.

Area of Science:

  • Genetics
  • Molecular Biology
  • Developmental Biology

Background:

  • Perinatal lethal osteogenesis imperfecta (OI) is a severe skeletal disorder.
  • It stems from heterozygous mutations in COL1A1 and COL1A2 genes, crucial for type I collagen synthesis.
  • Type I collagen is essential for bone structure and integrity.

Purpose of the Study:

  • To elucidate the genetic basis and molecular mechanisms of perinatal lethal osteogenesis imperfecta.
  • To understand how specific mutations in collagen genes lead to severe skeletal abnormalities.

Main Methods:

  • Analysis of COL1A1 and COL1A2 gene mutations.
  • Investigation of type I procollagen synthesis, processing, and secretion.
  • Assessment of collagen fiber organization and mineralization in affected tissues.

Related Experiment Videos

Main Results:

  • Frequent mutations involve glycine substitutions in the collagen triple helix domain, disrupting its stability.
  • Mutant pro-alpha chains interfere with normal collagen assembly, leading to reduced secretion and increased degradation.
  • Abnormal collagen organization and impaired mineralization result in severe skeletal defects.

Conclusions:

  • Mutations in COL1A1/COL1A2 genes cause perinatal lethal OI through dominant-negative effects on type I collagen.
  • The severity of OI is influenced by mutation type, location, and expression levels.
  • Understanding these mechanisms is vital for potential therapeutic strategies.